Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.

van Vlodrop IJH, Joosten SC, De Meyer T, Smits KM, Van Neste L, Melotte V, Baldewijns MMLL, Schouten LJ, van den Brandt PA, Jeschke J, Yi JM, Schuebel KE, Ahuja N, Herman JG, Aarts MJ, Bosman FT, Van Criekinge W, van Engeland M.

Clin Cancer Res. 2017 Apr 15;23(8):2006-2018. doi: 10.1158/1078-0432.CCR-16-1236. Epub 2016 Oct 18.

2.

Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.

Deckers IA, van Engeland M, van den Brandt PA, Van Neste L, Soetekouw PM, Aarts MJ, Baldewijns MM, Keszei AP, Schouten LJ.

Int J Epidemiol. 2017 Apr 1;46(2):622-631. doi: 10.1093/ije/dyw266.

PMID:
27789672
3.

Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer.

Schouten LJ, Deckers IA, van den Brandt PA, Baldewijns MM, van Engeland M.

Nutr Cancer. 2016 Oct;68(7):1097-107. doi: 10.1080/01635581.2016.1187283. Epub 2016 Jun 24.

PMID:
27340879
4.

Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.

Deckers IA, Schouten LJ, Van Neste L, van Vlodrop IJ, Soetekouw PM, Baldewijns MM, Jeschke J, Ahuja N, Herman JG, van den Brandt PA, van Engeland M.

Clin Cancer Res. 2015 Aug 1;21(15):3492-500. doi: 10.1158/1078-0432.CCR-14-2049. Epub 2015 Apr 22.

5.

Evidence for increased SOX3 dosage as a risk factor for X-linked hypopituitarism and neural tube defects.

Bauters M, Frints SG, Van Esch H, Spruijt L, Baldewijns MM, de Die-Smulders CE, Fryns JP, Marynen P, Froyen G.

Am J Med Genet A. 2014 Aug;164A(8):1947-52. doi: 10.1002/ajmg.a.36580. Epub 2014 Apr 15.

PMID:
24737742
6.

Long-term dietary sodium, potassium and fluid intake; exploring potential novel risk factors for renal cell cancer in the Netherlands Cohort Study on diet and cancer.

Deckers IA, van den Brandt PA, van Engeland M, Soetekouw PM, Baldewijns MM, Goldbohm RA, Schouten LJ.

Br J Cancer. 2014 Feb 4;110(3):797-801. doi: 10.1038/bjc.2013.771. Epub 2013 Dec 10.

7.

Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology.

Huysentruyt CJ, Baldewijns MM, Rüland AM, Tonk RJ, Vervoort PS, Smits KM, van de Beek C, Speel EJ.

Histopathology. 2011 Jun;58(7):1048-53. doi: 10.1111/j.1365-2559.2011.03859.x.

PMID:
21707706
8.

Analysis of promoter CpG island hypermethylation in cancer: location, location, location!

van Vlodrop IJ, Niessen HE, Derks S, Baldewijns MM, van Criekinge W, Herman JG, van Engeland M.

Clin Cancer Res. 2011 Jul 1;17(13):4225-31. doi: 10.1158/1078-0432.CCR-10-3394. Epub 2011 May 10.

9.

Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.

Theelen W, Speel EJ, Herfs M, Reijans M, Simons G, Meulemans EV, Baldewijns MM, Ramaekers FC, Somja J, Delvenne P, Hopman AH.

Am J Pathol. 2010 Oct;177(4):2022-33. doi: 10.2353/ajpath.2010.090901. Epub 2010 Sep 2.

10.

VHL and HIF signalling in renal cell carcinogenesis.

Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruïne AP.

J Pathol. 2010 Jun;221(2):125-38. doi: 10.1002/path.2689. Review.

PMID:
20225241
11.

The clinical spectrum of Blake's pouch cyst: report of six illustrative cases.

Cornips EM, Overvliet GM, Weber JW, Postma AA, Hoeberigs CM, Baldewijns MM, Vles JS.

Childs Nerv Syst. 2010 Aug;26(8):1057-64. doi: 10.1007/s00381-010-1085-2. Epub 2010 Mar 3.

12.

Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.

van Vlodrop IJ, Baldewijns MM, Smits KM, Schouten LJ, van Neste L, van Criekinge W, van Poppel H, Lerut E, Schuebel KE, Ahuja N, Herman JG, de Bruïne AP, van Engeland M.

Am J Pathol. 2010 Feb;176(2):575-84. doi: 10.2353/ajpath.2010.090442. Epub 2009 Dec 30.

13.

Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene.

Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de Bruïne AP.

Cell Oncol. 2009;31(5):371-82. doi: 10.3233/CLO-2009-0482.

14.

Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies.

Troyer DA, Lucia MS, de Bruïne AP, Mendez-Meza R, Baldewijns MM, Dunscomb N, Van Engeland M, McAskill T, Bierau K, Louwagie J, Bigley JW.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2717-22. doi: 10.1158/1055-9965.EPI-09-0068. Epub 2009 Sep 15.

15.

A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity.

Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen PB, van Poppel H.

BJU Int. 2009 Jun;103(12):1626-31. doi: 10.1111/j.1464-410X.2008.08272.x. Epub 2009 Jan 12.

16.

Genetics and epigenetics of renal cell cancer.

Baldewijns MM, van Vlodrop IJ, Schouten LJ, Soetekouw PM, de Bruïne AP, van Engeland M.

Biochim Biophys Acta. 2008 Apr;1785(2):133-55. doi: 10.1016/j.bbcan.2007.12.002. Epub 2007 Dec 15. Review.

PMID:
18187049
17.

High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.

Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.

Br J Cancer. 2007 Jun 18;96(12):1888-95. Epub 2007 May 15.

18.

Major brain lesions by intrauterine herpes simplex virus infection: MRI contribution.

Duin LK, Willekes C, Baldewijns MM, Robben SG, Offermans J, Vles J.

Prenat Diagn. 2007 Jan;27(1):81-4.

PMID:
17154224
19.

Prenatal diagnosis of bronchial atresia, early in pregnancy.

Duin LK, Marcus-Soekarman D, Baldewijns MM, Robben SG, Nijhuis JG.

Prenat Diagn. 2006 Apr;26(4):373-6. No abstract available.

PMID:
16566056

Supplemental Content

Loading ...
Support Center